Twin Lakes Capital Management’s BioAtla BCAB Stock Holding History

Twin Lakes Capital Management’s Portfolio BCAB Stock Details BCAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.16K	Sell	144 -36	-20%	-$421	﹤0.01%	213
2025 Q4	$5.11K	Hold	180	–	–	﹤0.01%	203
2025 Q3	$6.19K	Hold	180	–	–	﹤0.01%	200
2025 Q2	$3.56K	Hold	180	–	–	﹤0.01%	205
2025 Q1	$3.12K	Hold	180	–	–	﹤0.01%	205
2024 Q4	$5.32K	Sell	180 -30	-14%	-$2.52K	﹤0.01%	213
2024 Q3	$18.5K	Hold	210	–	–	0.01%	182
2024 Q2	$14.4K	Hold	210	–	–	0.01%	186
2024 Q1	$36.1K	Hold	210	–	–	0.02%	156
2023 Q4	$25.8K	Hold	210	–	–	0.02%	166
2023 Q3	$17.9K	Hold	210	–	–	0.01%	186
2023 Q2	$31.5K	Hold	210	–	–	0.02%	156
2023 Q1	$28.1K	Hold	210	–	–	0.02%	158
2022 Q4	$86.6K	Buy	210 +30	+17%	+$12.4K	0.07%	108
2022 Q3	$69K	Buy	+180	New	+$58.9K	0.06%	118
2022 Q2	–	Sell	-180	Closed	-$45K	–	162
2022 Q1	$45K	Buy	+180	New	+$75.3K	0.03%	163

Other funds holding BCAB

ACA

Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Twin Lakes Capital Management's BCAB Position: Q1 2026 in Review

Twin Lakes Capital Management reduced its BioAtla (BCAB) stake by 20% in Q1 2026, selling an estimated $421 and leaving 144 shares worth $1.16K. The position accounts for ﹤0.01% of the portfolio, ranked #213.

Twin Lakes Capital Management first reported a position in BCAB in Q1 2022 and has held it in 16 quarters since. The position peaked at $86.6K in Q4 2022. 36 funds tracked by Wall St. Rank hold BCAB as of Q1 2026.

Twin Lakes Capital Management held 144 shares of BioAtla worth $1.16K as of Q1 2026.
Twin Lakes Capital Management sold 36 BioAtla shares in Q1 2026, an estimated $421.
BioAtla made up ﹤0.01% of Twin Lakes Capital Management's portfolio in Q1 2026, its #213 holding.
Twin Lakes Capital Management first reported a position in BioAtla in Q1 2022 and has held it in 16 quarters since.
Twin Lakes Capital Management's BioAtla position peaked at $86.6K in Q4 2022.
36 funds tracked by Wall St. Rank held BioAtla as of Q1 2026.

Based on Twin Lakes Capital Management's 13F filing for Q1 2026, filed 18 May 2026.